Technical innovations in peritoneal dialysis (PD), now used widely for the long-term
treatment of ESRD, have significantly reduced therapy-related complications, allowing …

Fibrosis is part of a tissue repair response to injury, defined as increased deposition of
extracellular matrix. In some instances, fibrosis is beneficial; however, in the majority of …

Lay summary Peritoneal dialysis (PD) uses the peritoneal membrane for dialysis. The
peritoneal membrane is a thin layer of tissue that lines the abdomen. The lining is used as a …

Long-term peritoneal dialysis causes morphologic and functional changes in the peritoneal
membrane. Although mesothelial-mesenchymal transition of peritoneal mesothelial cells is a …

Peritoneal dialysis (PD) is a renal replacement therapy for patients with end-stage renal
disease that is equivalent to hemodialysis with respect to adequacy, mortality, and other …

Abdominal surgeries are lifesaving procedures but can be complicated by the formation of
peritoneal adhesions, intra-abdominal scars that cause intestinal obstruction, pain, infertility …

Progressive peritoneal fibrosis affects patients receiving peritoneal dialysis (PD) and has no
reliable treatment. The mechanisms that initiate and sustain peritoneal fibrosis remain …

During peritoneal dialysis (PD), mesothelial cells undergo mesothelial-to-mesenchymal
transition (MMT), a process associated with peritoneal-membrane dysfunction. Because TGF …

Peritoneal dialysis (PD) is an efficient renal replacement therapy for patients with end-stage
renal disease. Even if it ensures an outcome equivalent to hemodialysis and a better quality …

Peritoneal dissemination is a frequent metastatic route for cancers of the ovary and
gastrointestinal tract. Tumour cells metastasize by attaching to and invading through the …